Archive

Hemophilia B Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Amarna therapeutics, Catalyst Biosciences, Freeline

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes key companies continuously working towards developing Hemophilia B treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read Full Article

Dup15q Syndrome Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Hoffmann-La Roche, Takeda

“Dup15q Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Dup15q Syndrome, historical and forecasted epidemiology as well as the Dup15q Syndrome market trends in

Read Full Article

Essential Thrombocythemia Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | MorphoSys AG, Jubilant Therapeutics Inc., Kartos

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Essential Thrombocythemia pipeline constitutes 6+ key companies continuously working towards developing 6+ Essential Thrombocythemia treatment therapies, analysis of Clinical Trials,

Read Full Article

Chronic Lymphocytic Leukemia Pipeline Assessment, 2023 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, & Clinical Trials | NovalGen Ltd, Genmab, Ascentage

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Chronic Lymphocytic Leukemia pipeline constitutes 55+ key companies continuously working towards developing 60+ Chronic Lymphocytic Leukemia treatment therapies, analysis of

Read Full Article

Rare NRG1 Fusion Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Hummingbird Bioscience, Merus, Elevation Oncology

“Rare NRG1 Fusion Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Rare NRG1 Fusion, historical

Read Full Article

Gene and Cell Therapies Targeting CNS Disorders Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

“Gene and Cell Therapies Targeting CNS Disorders Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the

Read Full Article

Triple Negative Breast Cancer Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | HiberCell, Inc

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Triple Negative Breast Cancer pipeline constitutes 75+ key companies continuously

Read Full Article

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Pfizer, AstraZeneca, Lepu Biopharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 30+ key companies

Read Full Article

Food Allergy Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Merck & Co, AstraZeneca, Mabylon

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Food Allergy pipeline constitutes 30+ key companies continuously working towards

Read Full Article

Photoacoustic Imaging Market is Anticipated to Grow at a CAGR of 16% By 2031

Photoacoustic Imaging Market Report 2031 Photoacoustic Imaging Market By Product (Photoacoustic Tomography, Photoacoustic Microscopy), By Type (Pre-clinical, Clinical), By Application

Read Full Article

Categories